Who is sponsoring NCT03191344?

NCT03191344 is sponsored by Fujian Medical University.

What drugs are being tested in NCT03191344?

Interventions in NCT03191344: with IPSS.

What condition does NCT03191344 study?

NCT03191344 studies Intraoperative Parathyroid Scores System.

Is NCT03191344 still recruiting?

NCT03191344 is currently status unknown. Last updated 18 September 2018.

Last reviewed 2018-09-18 · How we verify

NCT03191344: IPSS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extended Application of Intraoperative Parathyroid Scores System(IPSS) in Thyroidectomy

Status unknown Last updated 18 September 2018

What this trial tests

trial testing with IPSS in Intraoperative Parathyroid Scores System in 300 participants. Status unknown.

Timeline

1 July 2017

Primary endpoint
1 July 2019

1 July 2019

Quick facts

Lead sponsor	Fujian Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 July 2017
Primary completion	1 July 2019
Estimated completion	1 July 2019
Sites	1 location across China

Drugs / interventions tested

with IPSS

Conditions studied

Intraoperative Parathyroid Scores System — all drugs for Intraoperative Parathyroid Scores System →

Sponsor

Fujian Medical University

Who can join

Under 60, any sex, with Intraoperative Parathyroid Scores System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

after established the Intraoperative Parathyroid Scores System (IPSS) for thyroidectomy we further extented the clinical value of Intraoperative Parathyroid Scores System in Treatment decisions of calcium treatment time and improve recognition skills of parathyroid in Clinicians

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fujian Medical University trials

Trials by the same sponsor.

NCT07314203 — Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastr · Phase 3 · not yet recruiting
NCT07491263 — Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Le · Phase 1 · not yet recruiting
NCT07275034 — A Virtual Reality-Based Horticultural Planting Program for Elderly With Subthreshold Depression · NA · not yet recruiting
NCT07383909 — Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery · NA · recruiting
NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03191344 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fujian Medical University
Last refreshed: 18 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03191344.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing